Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Amaryl (glimepiride) tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- June 2009

 

Summary View

 

CLINICAL PHARMACOLOGY

Drug Interactions
  • Drugs that may potentiate the hypoglycemic action of sulfonylureas: disopyramide, fluoxetine, and quinolones added

WARNINGS

  • persons allergic to other sulfonamide derivatives may develop an allergic reaction to glimepiride

PRECAUTIONS

  • hypoglycemia may be difficult to recognize in patients with autonomic neuropathy 

ADVERSE REACTIONS

  • hypersensitivity reactions worsening: dyspnea, fall in blood pressure, and shock
-
-